دورية أكاديمية

Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers.

التفاصيل البيبلوغرافية
العنوان: Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers.
المؤلفون: Piazzi, G, Selgrad, M, Garcia, M, Ceccarelli, C, Fini, L, Bianchi, P, Laghi, L, D'Angelo, L, Paterini, P, Malfertheiner, P, Chieco, P, Boland, C R, Bazzoli, F, Ricciardiello, L
المصدر: British Journal of Cancer; 4/30/2013, Vol. 108 Issue 8, p1750-1756, 7p, 2 Charts, 4 Graphs
مصطلحات موضوعية: COLON cancer, WNT genes, CELLULAR signal transduction, GENETIC regulation, PROMOTERS (Genetics), METHYLATION, DEOXYCYTIDINE
مستخلص: Background:Aberrant activation of the canonical WNT signaling is a feature of colorectal cancer (CRC). Van-Gogh-like 2 (VANGL2) belongs to the non-canonical WNT pathway whose activation inhibits canonical WNT signaling. In this study, we investigated the role of VANGL2 and its epigenetic regulation in CRC.Methods:Van-Gogh-like 2 expression and promoter methylation after 5-aza-2′-deoxycytidine (5-aza) treatment were evaluated in CRC cells. DNA samples from 418 sporadic CRCs were tested for VANGL2 promoter methylation and microsatellite instability (MSI). Proliferation, colony formation and activation of the WNT pathway were tested in cells after VANGL2 overexpression.Results:Van-Gogh-like 2 mRNA was significantly higher in 5-aza-treated RKO, LOVO and SW48, whereas no differences were found in SW480. Van-Gogh-like 2 was fully methylated in RKO, SW48, HCT116, DLD1 and Caco2; partially methylated in LOVO, LS174T and SW837; and unmethylated in SW480, SW620 and HT29. Higher expression of VANGL2 mRNA was found in the unmethylated cell lines. In CRC specimens (8.93% MSI), methylated VANGL2 was associated with MSI, higher grade, proximal colon location and BRAF mutation. Van-Gogh-like 2 overexpression in SW480 significantly decreased proliferation, colony formation and β-catenin levels.Conclusion:Van-Gogh-like 2 is frequently methylated in MSI-CRCs with BRAF mutation and may act as a tumour suppressor gene, counteracting WNT/β-catenin signaling. [ABSTRACT FROM AUTHOR]
Copyright of British Journal of Cancer is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00070920
DOI:10.1038/bjc.2013.142